CERS Cerus Corporation Stock Quote

CERS [NASD]

Index	-	P/E	-	EPS (ttm)	-0.28	Insider Own	3.10%	Shs Outstand	174.48M	Perf Week	2.87%
Market Cap	817.43M	Forward P/E	-	EPS next Y	-0.24	Insider Trans	-12.81%	Shs Float	171.39M	Perf Month	4.81%
Income	-49.20M	PEG	-	EPS next Q	-0.07	Inst Own	80.00%	Short Float	5.16%	Perf Quarter	-7.22%
Sales	173.00M	P/S	4.73	EPS this Y	13.00%	Inst Trans	0.37%	Short Ratio	4.65	Perf Half Y	-31.28%
Book/sh	0.46	P/B	10.89	EPS next Y	14.30%	ROA	-21.80%	Target Price	9.40	Perf Year	-14.51%
Cash/sh	0.67	P/C	7.53	EPS next 5Y	-	ROE	-59.90%	52W Range	4.38 - 8.06	Perf YTD	-26.43%
Dividend	-	P/FCF	-	EPS past 5Y	12.50%	ROI	-32.00%	52W High	-37.80%	Beta	1.17
Dividend %	-	Quick Ratio	2.20	Sales past 5Y	32.40%	Gross Margin	59.30%	52W Low	14.38%	ATR	0.36
Employees	294	Current Ratio	2.60	Sales Q/Q	45.30%	Oper. Margin	-24.50%	RSI (14)	50.58	Volatility	6.80% 7.92%
Optionable	Yes	Debt/Eq	0.88	EPS Q/Q	31.90%	Profit Margin	-28.40%	Rel Volume	1.21	Prev Close	5.01
Shortable	Yes	LT Debt/Eq	0.69	Earnings	May 05 AMC	Payout	-	Avg Volume	1.90M	Price	5.01
Recom	1.40	SMA20	2.94%	SMA50	-1.87%	SMA200	-15.96%	Volume	0	Change	0.00%

Oct-08-20

Resumed

BTIG Research

Buy

Jun-16-20

Resumed

Cantor Fitzgerald

Overweight

Feb-26-20

Initiated

BTIG Research

Buy

Nov-13-19

Upgrade

BTIG Research

Neutral → Buy

Aug-28-19

Initiated

Stifel

Buy

Aug-23-19

Resumed

Stephens

Overweight

Jan-05-18

Resumed

Cantor Fitzgerald

Overweight

Dec-08-17

Resumed

BTIG Research

Neutral

Jul-07-16

Resumed

Cantor Fitzgerald

Buy

Dec-17-15

Downgrade

Wedbush

Outperform → Neutral

May-02-14

Reiterated

MLV & Co

Buy

$8.50 → $6

Apr-24-13

Reiterated

Cantor Fitzgerald

Buy

$5.50 → $6

Mar-15-13

Reiterated

MLV & Co

Buy

$7.50 → $8.50

Apr-17-12

Initiated

Cantor Fitzgerald

Buy

$5.50

Feb-29-12

Upgrade

Robert W. Baird

Neutral → Outperform

$3 → $6

Nov-10-11

Reiterated

MLV & Co

Buy

$4 → $5

Jun-03-11

Initiated

Wedbush

Outperform

Mar-04-11

Downgrade

Robert W. Baird

Outperform → Neutral

$4 → $3

Mar-09-10

Upgrade

Robert W. Baird

Neutral → Outperform

$3 → $5

Aug-26-09

Upgrade

Avondale

Mkt Perform → Mkt Outperform

$2 → $5

May-17-22 05:00AM	As the Red Cross moves to a pricey blood treatment method, hospitals call for more choice Fortune
May-16-22 09:55AM	Does Cerus (CERS) Have the Potential to Rally 89% as Wall Street Analysts Expect? Zacks
May-15-22 08:42AM	Cerus (NASDAQ:CERS) Has Debt But No Earnings; Should You Worry? Simply Wall St.
May-06-22 02:30AM	Cerus (CERS) Q1 2022 Earnings Call Transcript Motley Fool +10.00%
May-05-22 05:15PM	Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates Zacks -6.43%
04:00PM	Cerus Corporation Announces First Quarter 2022 Financial Results and Increases Full Year 2022 Product Revenue Guidance Range Business Wire
May-03-22 08:00AM	Cerus Corporation Announces New Manufacturing and Supply Agreement With Fresenius Kabi For INTERCEPT Blood System Sets Business Wire
Apr-28-22 08:35AM	Baxter International (BAX) Surpasses Q1 Earnings and Revenue Estimates Zacks
Apr-25-22 08:00AM	Cerus Corporation Announces Multi-Year Contract for the INTERCEPT Blood System for Platelets with the American Red Cross Business Wire +8.62%
Apr-21-22 08:00AM	Cerus Corporation to Release First Quarter 2022 Financial Results on May 5, 2022 Business Wire
Apr-07-22 11:39AM	Investing in Cerus (NASDAQ:CERS) five years ago would have delivered you a 31% gain Simply Wall St.
Feb-25-22 08:00AM	Cerus Corporation to Participate at the Cowen 42nd Annual Health Care Conference Business Wire
Feb-23-22 10:00AM	Does Cerus (CERS) Have the Potential to Rally 90% as Wall Street Analysts Expect? Zacks
Feb-22-22 10:00PM	Cerus (CERS) Q4 2021 Earnings Call Transcript Motley Fool
04:01PM	Cerus Corporation Announces Record Fourth Quarter and Full-Year 2021 Financial Results Business Wire
Feb-08-22 08:00AM	Cerus Corporation to Release Fourth Quarter and Full-Year 2021 Financial Results on February 22, 2022 Business Wire
Feb-07-22 04:05PM	Cerus Corporation to Participate in Upcoming Virtual Investor Conferences Business Wire
Feb-04-22 05:36AM	What Kind Of Shareholders Hold The Majority In Cerus Corporation's (NASDAQ:CERS) Shares? Simply Wall St.
Jan-28-22 01:38PM	Roubaix Capital, LLC Buys Treace Medical Concepts Inc, Alpha Teknova Inc, EnerSys, Sells Rogers ... GuruFocus.com
Jan-10-22 08:00AM	Cerus Corporation Announces Record Preliminary Fourth Quarter and Full-Year 2021 Product Revenue and Provides Business Update Business Wire
Dec-28-21 10:00AM	How Much Upside is Left in Cerus (CERS)? Wall Street Analysts Think 44% Zacks
Dec-06-21 04:43AM	Is Cerus (NASDAQ:CERS) Using Too Much Debt? Simply Wall St.
Nov-24-21 10:00AM	Wall Street Analysts Think Cerus (CERS) Could Surge 35%: Read This Before Placing a Bet Zacks
Nov-19-21 08:00AM	Cerus Corporation to Participate in Stephens Annual Investment Conference Business Wire
Nov-10-21 11:43AM	Notable Cerus Insider Trades $1.3M In Company Stock Benzinga
Nov-08-21 10:06AM	Chief Medical Officer Of Cerus Trades $2M In Company Stock Benzinga
08:00AM	Cerus Corporation to Participate in Stifel 2021 Virtual Healthcare Conference Business Wire
Nov-03-21 12:03PM	54 Stocks Moving In Wednesday's Mid-Day Session Benzinga +16.59%
08:04AM	Cerus Posts Lower Than Expected Q3 Loss; Raises FY21 Sales Guidance Benzinga
05:01AM	Cerus Corporation (CERS) Q3 2021 Earnings Call Transcript Motley Fool
Nov-02-21 05:25PM	Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:00PM	Cerus Corporation Announces Record Third Quarter 2021 Financial Results and Raises Full-Year Product Revenue Guidance Business Wire
Oct-29-21 08:47AM	Hedge Funds Are Piling Into Cerus Corporation (CERS) Insider Monkey
Oct-26-21 03:02PM	Analysts Estimate Cerus (CERS) to Report a Decline in Earnings: What to Look Out for Zacks
Oct-19-21 08:00AM	Cerus Corporation to Release Third Quarter 2021 Financial Results on November 2, 2021 Business Wire +5.25%
Oct-18-21 12:26PM	Cathie Woods Top 15 Small-Cap Stock Picks Insider Monkey
Oct-07-21 06:49AM	Investors in Cerus (NASDAQ:CERS) have made a return of 10% over the past five years Simply Wall St.
Oct-01-21 08:00AM	Cerus Corporation Applauds FDA Requirements Effective Today to Safeguard the U.S. Platelet Supply Business Wire
Sep-20-21 08:00AM	Cerus Corporation Announces INTERCEPT Fibrinogen Complex Customer Presentations at SABM Virtual Annual Meeting 2021 Business Wire
Sep-15-21 08:00AM	Cerus Corporation to Present at the 2021 Cantor Global Virtual Healthcare Conference Business Wire
Aug-15-21 01:26PM	Billionaire Ray Dalio Bets on These 3 Strong Buy Stocks TipRanks
Aug-10-21 08:30AM	Cerus Corporation Announces CMS Issuance of P-Codes for Hospital Outpatient Billing of INTERCEPT-Based Therapeutic Products Business Wire
Aug-04-21 08:30AM	Cerus Corporation Announces Appointment of Ann Lucena to Board of Directors Business Wire +20.66%
05:01AM	Cerus Corporation (CERS) Q2 2021 Earnings Call Transcript Motley Fool
02:48AM	What Type Of Shareholders Make Up Cerus Corporation's (NASDAQ:CERS) Share Registry? Simply Wall St.
Aug-03-21 05:15PM	Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates Zacks
04:00PM	Cerus Corporation Announces Record Second Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance Business Wire
06:30AM	Cerus Corporation Announces CMS Has Granted New Technology Add-On Payment for INTERCEPT Fibrinogen Complex Business Wire
Jul-27-21 03:02PM	Earnings Preview: Cerus (CERS) Q2 Earnings Expected to Decline Zacks
Jul-20-21 08:30AM	Cerus Corporation to Release Second Quarter 2021 Financial Results on August 3, 2021 Business Wire
Jul-14-21 08:30AM	Cerus Corporation and the Swiss Red Cross Celebrate 10 Years of Routine Use of INTERCEPT Blood System for Platelets Business Wire
Jun-30-21 08:30AM	Cerus Announces Collaboration with LifeSouth Community Blood Centers to Manufacture INTERCEPT® Fibrinogen Complex Business Wire
Jun-14-21 08:30AM	Cerus Corporation Celebrates World Blood Donor Day 2021 Business Wire
Jun-05-21 04:16AM	Cerus (NASDAQ:CERS) Has Debt But No Earnings; Should You Worry? Simply Wall St.
May-17-21 09:00AM	Cerus Corporation Announces Contract with Canadian Blood Services for INTERCEPT Blood System for Platelets Business Wire
May-05-21 09:30AM	Cerus Corporation (CERS) Q1 2021 Earnings Call Transcript Motley Fool +7.50%
May-04-21 05:35PM	Cerus (CERS) Reports Q1 Loss, Tops Revenue Estimates Zacks
04:01PM	Cerus Corporation Announces First Quarter 2021 Financial Results and Raises Full Year Product Revenue Guidance Business Wire
02:30PM	Cerus Corp. to Host Earnings Call ACCESSWIRE
Apr-20-21 08:30AM	Cerus Corporation to Release First Quarter 2021 Financial Results on May 4, 2021 Business Wire
Apr-06-21 02:46AM	Introducing Cerus (NASDAQ:CERS), A Stock That Climbed 22% In The Last Year Simply Wall St.
Mar-03-21 08:30AM	Cerus Corporation to Participate in Jefferies Virtual Global Plasma Summit Business Wire
Feb-26-21 10:01AM	Cerus Corporation (CERS) Q4 2020 Earnings Call Transcript Motley Fool
Feb-25-21 04:01PM	Cerus Corporation Announces Record Fourth Quarter and Full Year 2020 Financial Results Business Wire
02:30PM	Cerus Corp. to Host Earnings Call ACCESSWIRE
Feb-24-21 05:00PM	Cerus Corporation and Shandong Zhongbaokang Medical Implements Partner to Establish Joint Venture in China Business Wire
10:14AM	A Preview Of Cerus's Earnings Benzinga
Feb-11-21 08:30AM	Cerus Corporation to Release Fourth Quarter and Full Year 2020 Financial Results on February 25, 2021 Business Wire
Feb-05-21 01:39AM	Do Institutions Own Cerus Corporation (NASDAQ:CERS) Shares? Simply Wall St.
Feb-04-21 08:30AM	Cerus Corporation to Participate in Upcoming Virtual Investor Conferences Business Wire
Jan-23-21 11:30PM	Money Supply Is Up 26%, Inflation Coming? Cathie Woods Bitcoin Comments and Stock Picks Insider Monkey
Jan-11-21 08:30AM	Cerus Corporation Announces Preliminary Fourth Quarter and Full Year 2020 Product Revenue Business Wire
Dec-15-20 08:30AM	Cerus Distribution Partner, CEI, Announces Three-Year Tender Award with the Minas Gerais Hematology and Hemotherapy Center Foundation (HemoMinas) in Brazil for the INTERCEPT Blood System for Platelets Business Wire
Dec-11-20 10:55PM	Is CERS A Good Stock To Buy Now? Insider Monkey
Dec-07-20 12:11AM	Cerus (NASDAQ:CERS) Has Debt But No Earnings; Should You Worry? Simply Wall St.
Dec-04-20 07:00PM	Cerus Corporation Announces Presentation of Study Results with INTERCEPT-treated COVID-19 Convalescent Plasma at the American Society of Hematology Annual Meeting Business Wire
Nov-30-20 12:00PM	Cerus (CERS) Is Up 2.47% in One Week: What You Should Know Zacks
08:30AM	Cerus Corporation Announces FDA Approval for INTERCEPT Blood System for Cryoprecipitation Business Wire
Nov-20-20 12:00PM	All You Need to Know About Cerus (CERS) Rating Upgrade to Buy Zacks
Nov-12-20 08:30AM	Cerus Corporation to Participate in Upcoming Virtual Investor Conferences Business Wire
Nov-01-20 07:59AM	Cerus Corporation (NASDAQ:CERS) Third-Quarter Results: Here's What Analysts Are Forecasting For Next Year Simply Wall St.
Oct-30-20 03:30PM	Cerus Corporation (CERS) Q3 2020 Earnings Call Transcript Motley Fool -5.49%
Oct-29-20 06:05PM	Cerus (CERS) Reports Q3 Loss, Tops Revenue Estimates Zacks
04:02PM	Cerus Corporation Announces Record Third Quarter 2020 Results Business Wire
02:30PM	Cerus Corp.to Host Earnings Call ACCESSWIRE
Oct-28-20 10:13AM	Earnings Outlook for Cerus Benzinga -6.88%
Oct-22-20 12:34PM	Cerus (CERS) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release Zacks
07:44AM	Is Cerus' (NASDAQ:CERS) 120% Share Price Increase Well Justified? Simply Wall St.
Oct-19-20 08:30AM	Cerus Corporation to Release Third Quarter 2020 Financial Results on October 29, 2020 Business Wire
Oct-13-20 08:30AM	Cerus Corporation Announces Five-Year FDA Contract for the Development of Next Generation Pathogen Reduction Technology to Treat Whole Blood Business Wire
Sep-28-20 08:30AM	Cerus Corporation Announces Schedule of Presentations at the AABB 2020 Virtual Annual Meeting Business Wire
Sep-16-20 07:49AM	Key Things To Understand About Cerus' (NASDAQ:CERS) CEO Pay Cheque Simply Wall St.
Sep-09-20 08:30AM	Cerus Corporation to Participate in Upcoming Virtual Investor Conferences Business Wire +5.28%
Aug-26-20 01:08PM	The Zacks Analyst Blog Highlights: TTOO, KMDA and CERS Zacks
Aug-25-20 08:38AM	The Daily Biotech Pulse: Altimmune Reports Positive Preclinical Data For Intranasal COVID-19 Vaccine, AbbVie Licenses Morphic's Drug, Viveve Clinical Readout Benzinga -7.54%
Aug-12-20 09:26AM	Did Hedge Funds Make The Right Call On Cerus Corporation (CERS) ? Insider Monkey
Aug-11-20 06:48AM	Have Insiders Been Buying Cerus Corporation (NASDAQ:CERS) Shares This Year? Simply Wall St.
Aug-07-20 08:30AM	Cerus INTERCEPT Blood System Kit Shipments Surpass 7.5 Million Treatable Platelet and Plasma Doses Since Launch Business Wire
Aug-05-20 02:01AM	Cerus Corporation (CERS) Q2 2020 Earnings Call Transcript Motley Fool
Aug-04-20 05:15PM	Cerus (CERS) Reports Q2 Loss, Tops Revenue Estimates Zacks

Cerus Corporation, a biomedical products company, focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended for transfusion. The company offers INTERCEPT Blood Systems for platelets and plasma, which is designed to inactivate blood-borne pathogens in platelets and plasma donated for transfusion; INTERCEPT Blood System for red blood cells to inactivate blood-borne pathogens in red blood cells donated for transfusion; and INTERCEPT Blood System for Cryoprecipitation that uses its plasma system to produce pathogen reduced cryoprecipitated fibrinogen complex for the treatment and control of bleeding, including massive hemorrhage associated with fibrinogen deficiency, as well as pathogen reduced plasma, cryoprecipitate reduced. It sells platelet and plasma systems through its direct sales force and distributors in the United States, Europe, the Commonwealth of Independent States, the Middle East, Latin America, and internationally. Cerus Corporation has collaboration with LifeSouth Community Blood Centers to manufacture INTERCEPT Fibrinogen Complex. The company was incorporated in 1991 and is headquartered in Concord, California.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Green Kevin Dennis	Chief Financial Officer	May 10	Sale	4.98	57,335	285,373	222,999	May 12 06:36 PM
Jayaraman Vivek K	Chief Operating Officer	Mar 14	Sale	5.04	41,734	210,320	327,097	Mar 15 09:59 PM
Greenman William Mariner	President and CEO	Mar 14	Sale	5.04	165,021	831,634	1,885,141	Mar 15 10:00 PM
CORASH LAURENCE M	Chief Scientific Officer	Mar 14	Sale	5.04	30,307	152,735	2,101,434	Mar 15 09:57 PM
Green Kevin Dennis	Chief Financial Officer	Mar 14	Sale	5.04	32,102	161,780	251,847	Mar 15 09:55 PM
Benjamin Richard J	Chief Medical Officer	Mar 14	Sale	5.04	30,307	152,735	157,383	Mar 15 09:50 PM
Moore Carol	SVP Reg. & Quality	Mar 14	Sale	5.04	28,513	143,695	257,192	Mar 16 06:29 PM
Menard Chrystal	Chief Legal Officer	Mar 14	Sale	5.04	30,307	152,734	149,589	Mar 16 06:25 PM
Greenman William Mariner	President and CEO	Feb 25	Option Exercise	3.75	380,000	1,425,000	1,902,281	Mar 01 09:18 PM
Greenman William Mariner	President and CEO	Feb 25	Sale	5.70	308,263	1,757,043	1,594,018	Mar 01 09:18 PM
Moore Carol	SVP Reg. & Quality	Jan 03	Option Exercise	3.66	19,059	69,756	200,335	Jan 05 07:24 PM
Moore Carol	SVP Reg. & Quality	Jan 03	Sale	7.00	19,059	133,417	181,276	Jan 05 07:24 PM
CORASH LAURENCE M	Chief Scientific Officer	Dec 17	Option Exercise	3.75	5,000	18,750	2,027,586	Dec 21 05:29 PM
CORASH LAURENCE M	Chief Scientific Officer	Dec 13	Option Exercise	3.75	40,000	150,000	2,022,586	Dec 15 08:57 PM
SCHULZE GAIL	Director	Nov 09	Option Exercise	2.86	25,000	71,500	53,116	Nov 09 08:43 PM
SCHULZE GAIL	Director	Nov 09	Sale	7.54	25,000	188,430	28,116	Nov 09 08:43 PM
Moore Carol	SVP Reg. & Quality	Nov 05	Option Exercise	3.75	110,000	412,500	289,555	Nov 09 08:38 PM
Moore Carol	SVP Reg. & Quality	Nov 05	Sale	7.94	110,000	873,191	181,276	Nov 09 08:38 PM
Benjamin Richard J	Chief Medical Officer	Nov 03	Option Exercise	4.56	165,000	753,133	176,035	Nov 05 07:41 PM
Green Kevin Dennis	Chief Financial Officer	Nov 03	Option Exercise	3.75	95,000	356,250	248,740	Nov 05 07:47 PM
Menard Chrystal	Chief Legal Officer	Nov 03	Sale	7.70	40,000	308,000	67,038	Nov 05 07:51 PM
Green Kevin Dennis	Chief Financial Officer	Nov 03	Sale	7.00	95,741	670,187	152,999	Nov 05 07:47 PM
Benjamin Richard J	Chief Medical Officer	Nov 03	Sale	7.68	165,000	1,267,750	76,035	Nov 05 07:41 PM
Swisher Daniel N JR	Director	Aug 04	Option Exercise	2.86	12,877	36,828	106,231	Aug 05 05:08 PM
Swisher Daniel N JR	Director	Aug 04	Sale	6.25	12,877	80,481	93,354	Aug 05 05:08 PM
Greenman William Mariner	President and CEO	Aug 03	Option Exercise	2.08	100,000	208,000	1,518,672	Aug 05 05:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google

Upgrade your FINVIZ experience